UMC Utrecht receives grant for microbiota-boosted cancer therapy
Drug Discovery World
SEPTEMBER 26, 2022
UMC Utrecht and its partners have received a research grant to unravel how the intestinal microbiota can be exploited to boost cancer immunotherapy and limit therapy side-effects. . Close to €800,000 was awarded by Health~Holland to a public-private partnership between UMC Utrecht, Artizan Biosciences, Inc.
Let's personalize your content